Last reviewed · How we verify

Dermatosis of scalp — Treatment Landscape & Competitive Intelligence

Dermatosis of scalp (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Dermatosis of scalp, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Temovate CLOBETASOL PROPIONATE Fougera Pharms Corticosteroid Glucocorticoid receptor 1985-01-01
Betamethasone Valerate BETAMETHASONE VALERATE Fougera Pharms Inc Corticosteroid Glucocorticoid receptor 1967-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. · 1 drug in Dermatosis of scalp
  2. Fougera Pharms · 1 drug in Dermatosis of scalp
  3. Fougera Pharms Inc · 1 drug in Dermatosis of scalp

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Dermatosis of scalp:

Cite this brief

Drug Landscape (2026). Dermatosis of scalp — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/dermatosis-of-scalp. Accessed 2026-06-10.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing